Contents
Academy · Research Publication · Publication journey checklists
Checklists for Each Stage of the Publication Journey: Timing, Evidence and Use
A checklist used at the protocol stage functions as a design instrument; the same checklist used at submission functions as a compliance form and achieves considerably less. Studies of diagnostic accuracy reporting found that papers addressed only 9.1 to 14.3 of 25 STARD items on average, with an improvement of 1.41 items after publication of the guideline. Structured review, when used appropriately, is nevertheless the one intervention in this field supported by randomised evidence.
Each stage of the publication process has a small number of checks that identify most of the problems arising at that stage, and nearly all are easier to satisfy before the stage than after it. The evidence for this is stronger than for most publishing advice: in a masked randomised trial, reviewing manuscripts against a reporting guideline increased the proportion that improved from 20% to 43%. The same evidence indicates the limits of the approach: the adherence gains measured in the literature are small, and a checklist cannot create a decision that was never made. This article sets out what should be checked at each stage and why timing is the principal determinant of effectiveness.
Learning objectives
- The demonstrated effects of checklist-based review and the small magnitude of measured adherence gains
- Why a reporting guideline belongs in the protocol rather than in the submission package
- The guideline applicable to each study design, with links to each
- The decisions editors make at desk evaluation and the corresponding pre-submission checks
- Checks to be performed at revision, at proof stage and after publication
- Submission of a completed checklist that is usable rather than decorative
Common misconceptions
- “A checklist is a formality of submission.” A checklist is a drafting instrument. Several items require a decision and its justification, and justifications can be written honestly only before the results exist.
- “Reporting guidelines have resolved deficiencies in reporting.” Across 16 investigations covering 1,496 diagnostic accuracy articles, the mean number of STARD items reported ranged from 9.1 to 14.3 out of 25, and publication of the guideline was associated with an improvement of only 1.41 items (95% CI 0.65 to 2.18).
- “Journal endorsement guarantees compliance.” Endorsement is associated with a small benefit: across 130 coronary CT angiography studies in 44 journals, STARD scores averaged 15.4 in journals that had adopted the checklist, compared with 14.1 in those that had not.
- “A single problem leads to the rejection of a paper.” Manuscripts rejected before review averaged three or more distinct recorded reasons each; correcting only the problem that was noticed is rarely sufficient.
- “Every contributor is eligible for the author list.” The ICMJE Recommendations require an author to meet all four authorship criteria, not merely one; authorship is therefore a matter to be settled at the protocol stage rather than at submission.
Capabilities and limitations of checklists
The strongest result is considered first, because it provides the principal justification for the approach. Cobo and colleagues, in a masked randomised trial published in the BMJ, allocated 92 manuscripts to an additional review against a reporting guideline or to usual handling 22. The proportion that improved from baseline rose from 20% to 43%, a relative risk of 2.21 and a number needed to treat of approximately 4.2 manuscripts reviewed to improve one. Structured review against an instrument therefore has a measurable effect 22,26.
The limitations are equally well documented. Korevaar and colleagues, in Evidence-Based Medicine, pooled 16 investigations covering 1,496 diagnostic accuracy articles and found the mean number of STARD items reported ranged from 9.1 to 14.3 out of 25, with publication of the guideline associated with an improvement of 1.41 items (95% CI 0.65 to 2.18) 18. Walther and colleagues, in Radiology, examined 130 coronary CT angiography studies across 44 journals and found mean STARD scores of 15.4 in adopting journals against 14.1 in non-adopting ones, with scores rising by about 0.30 points a year 17.
Taken together, the existence of a guideline changes reporting slightly; endorsement by a journal changes reporting slightly more; and systematic application of the guideline to a specific manuscript changes that manuscript substantially 17,18. The effective intervention is the systematic application of the guideline, not the document itself. For this reason, the stage at which the guideline is applied matters more than the choice of list.
How much reporting guidelines have actually changed reporting
| Study | What was examined | Finding |
|---|---|---|
| Cobo and colleagues, BMJ | 92 manuscripts randomised to added review against a reporting guideline | Share improving from baseline rose from 20% to 43%; relative risk 2.21; about 4.2 reviewed to improve 1 |
| Korevaar and colleagues, Evidence-Based Medicine | 16 investigations covering 1,496 diagnostic accuracy articles | Mean STARD items reported ranged from 9.1 to 14.3 of 25; improvement after publication of 1.41 items (95% CI 0.65 to 2.18) |
| Walther and colleagues, Radiology | 130 coronary CT angiography studies in 44 journals | Mean STARD score 15.4 in adopting journals against 14.1 in non-adopting (p = 0.018); scores rising about 0.30 points a year |
Figures as reported in each study. The three ask different questions — an intervention trial, adherence across a field, and journal endorsement — and are shown together to separate what the document achieves from what working through it achieves.
The importance of timing
Close reading of any reporting checklist reveals two kinds of item. The first concerns what was done: the number of participants, the test used, the primary outcome. These items can be answered at any point, including immediately before submission. The second concerns what was decided and why: the rationale for the sample size, the synthesis model, the comparator and the subgroups. These answers can be given candidly at the protocol stage but are difficult to give afterwards, because once the results exist, every justification is written in their light.
This is the principal argument for using the guideline early. An item asking why a particular analysis was chosen functions as a design prompt in a protocol but becomes a reconstruction at submission. An item asking whether outcomes were pre-specified records a plan in a protocol but becomes an admission at submission. Completing the checklist late is not more difficult; it is less accurate.
The same point applies in practice to authorship. The ICMJE Recommendations require an author to meet all four criteria (substantial contribution, drafting or critical revision, final approval, and accountability), and agreement on who will meet them is straightforward before the data exist and considerably more difficult once the analysis is complete 1. Authorship should therefore be addressed in the protocol.
Stage 1: protocol
The following should be settled before data collection begins: the research question, stated in one sentence; the design and the reason it can answer that question; the single primary outcome, with its measurement and timing; the sample size and its underlying assumptions; the analysis plan, including the handling of missing data and the population to be analysed; the planned subgroup and sensitivity analyses; and the registration.
Registration is the item that allows the least opportunity for later correction. Prospective registration is expected for clinical trials and increasingly for systematic review protocols, and a retrospective registration is evident to anyone who examines the dates 1. Use SPIRIT for a trial protocol and the PRISMA extension for protocols for a review; see trial registration for what journals require.
The following should also be settled at this stage: the author list and the criteria each contributor is expected to meet, the data management and sharing plan, the ethics approval and consent arrangements, and the reporting guideline that the eventual paper will follow. The last of these takes approximately five minutes and usefully reorganizes the protocol.
Stage 2: drafting
The guideline appropriate to the study design should be selected and the methods drafted against it item by item, with the location at which each item is addressed recorded 10,23. The table below maps the principal guidelines. Two cautions apply: the relevant extension should be used where one exists for the review or study type, because the main checklist omits what that type most requires; and, for every item that cannot be located, authors should determine whether it is a reporting gap that can still be remedied in writing or a conduct gap that cannot.
This distinction is the most valuable part of the process. A reporting gap requires approximately an hour of work. A conduct gap, such as the absence of a pre-specified primary outcome, of allocation concealment or of a second screener, is a limitation to be stated explicitly rather than a deficiency to be addressed through drafting. Conflating the two results in methods sections that are more confident than the study warrants.
The abstract should be drafted last, after the results are final, and should receive a disproportionate share of drafting time; the page on editing and proofreading explains why that short text carries so much weight in the editorial decision.
Which reporting guideline applies to which design
| If your study is | Draft against | Notes |
|---|---|---|
| A parallel-group randomised trial | CONSORT 2010, and the 2025 update | Extensions exist for cluster, pilot, non-inferiority and other designs |
| A trial protocol | SPIRIT | Intended to structure the protocol, not to report it retrospectively |
| A systematic review or meta-analysis | PRISMA 2020 | See what PRISMA is and is not; the extension appropriate to the review type should be used |
| A diagnostic accuracy study | STARD 2015 | Adherence is poor in practice (see the adherence table below) |
| An observational study | STROBE, with the cohort, case-control or cross-sectional version | The version appropriate to the specific design should be used |
| A case report | CARE | Patient consent for publication is a separate requirement |
| Qualitative research | COREQ or SRQR | COREQ for interviews and focus groups; SRQR is broader |
| A quality improvement study | SQUIRE | Reports context and iteration, which other guidelines omit |
| An economic evaluation | CHEERS | Model structure and assumptions have their own items |
| An intervention that others must replicate | TIDieR | To be used alongside CONSORT or STROBE, not in place of them |
| A clinical practice guideline | AGREE reporting checklist and AGREE II | One is for reporting, the other for appraisal |
Each guideline as published. Our checklist library holds the full set, including extensions not listed here.
Stage 3: pre-submission
Before submission, the manuscript should be checked against the criteria on which editors base their decisions. Saragih and colleagues surveyed journal editors on desk evaluation and found that their acceptance judgements depended on topic relevance (95.02%), conformity with the journal’s scope (92.85%), novelty (90.47%), significance (88.09%) and originality (80.93%) 5. Each of these is a property of the study and its fit with the journal, not of the prose.
The pre-submission checks are therefore as follows: whether the authors can state, in one sentence each, what is new and why the journal’s readers require it; whether two of the journal’s own recent papers can be cited as context; whether the article type is one the journal lists, with its word limit observed; and whether the abstract reports the design, population, primary outcome and an effect size with its uncertainty.
A further finding should inform routine practice. In Meyer and colleagues’ audit of 369 manuscripts rejected before external review, manuscripts averaged three or more distinct recorded reasons each 14. Problems tend to occur in groups, so a pre-submission check that stops at the first defect identified is incomplete; the entire list should be worked through. The rejection-reasons page describes those reasons, and the submission hub covers the package itself.
The criteria that editors report weighing when deciding whether to send a manuscript for review. Source: Saragih E, Saddhono K, Yannuar N, Sumbayak DM. Scholarly Manuscript Assessment: Scientific Journal Editor Desk Evaluation. Malaysian Journal of Library & Information Science.
Stage 4: submission
The submission-stage checks are administrative and strictly applied, because an incomplete package is returned by the editorial office and causes a delay of several days. The following should be collected, in the journal’s own wording: the name of the ethics committee and the approval reference; the consent statement; the funding source and the funder’s role; competing interests for every author; the data availability statement; the registration number and date; author contributions; and any prior presentation, preprint or thesis chapter.
The completed reporting checklist should be uploaded with the section or page at which each item is addressed. A column of ticks is of no value to an editor and unhelpful to a reviewer, whereas an item-to-location map is immediately usable and, in Pubrica’s experience, alters the tone of the methodological comments received.
Each author should be confirmed individually against all four ICMJE criteria, as submission systems increasingly require, and the person who approves the final version should have read the version being submitted 1.
The completed checklist you upload
Unverifiable
Item 6. Eligibility criteria — Reported: Yes. Item 7. Information sources — Reported: Yes. Item 8. Search strategy — Reported: Yes. Item 9. Selection process — Reported: Yes. Item 11. Risk of bias assessment — Reported: Yes.
Nothing can be checked. “Yes” is a claim about the manuscript that the reader must verify by searching the manuscript.
No locations. The purpose of a completed checklist is to spare a reviewer that search; this version has the opposite effect.
Hides the gaps. A column of affirmative responses makes an unmet item appear met, which is a worse outcome than an accurate “not reported”.
No distinction between a reporting gap and a conduct gap. An item that is unreported because the corresponding step was not undertaken is the one a reader most needs to have identified.
It was very probably completed immediately before submission. It therefore contributed nothing to the manuscript.
Usable by a reviewer
Item 6. Eligibility criteria — Methods, page 4, lines 78–91; full criteria table in Supplementary Table S1. Item 7. Information sources — Methods, page 4, lines 92–99: MEDLINE, Embase, CENTRAL and CINAHL, all searched from inception to 14 March 2025, plus reference lists of included studies. Item 8. Search strategy — Supplementary File 2 gives the full strategy per database, as run, with dates and yields. Item 9. Selection process — Methods, page 5, lines 104–112: two reviewers screened independently at title and abstract and at full text, disagreements resolved by a third. Item 11. Risk of bias assessment — Methods, page 5, lines 118–126: two assessors independently, tool named, disagreements resolved by discussion; results in Table 2 and Supplementary Table S3.
Every item carries a location to the line, so that an editor or reviewer can verify the entire list within a few minutes.
Where an item spans the manuscript and a supplement, both locations are given, as search reporting and risk-of-bias items usually require.
The entries are specific enough to be verifiable: databases, dates, number of screeners and resolution procedure.
An unmet item can be marked “not reported” with a reason in the same format, which conveys candour rather than omission.
A list of this kind can be produced only from a checklist maintained throughout the review, which is the principal point.
A tick column asserts compliance; a location map demonstrates it. The latter requires an hour if the checklist has been maintained from the protocol stage, and a day of reconstruction if it has not.
Stage 5: revision
A revision has its own checklist, concerned as much with reconciliation as with response. Every comment should be assigned to one of three categories: factually answerable, where the reviewer overlooked something already present; remediable through work that can still be undertaken; and determined at the time the study was designed 3. The first two categories should be addressed and the third stated as a limitation.
The manuscript should then be reconciled. If the analysis has changed, every affected number must be updated in the abstract, the results, the tables, the figures and the discussion; discrepancies between superseded and revised figures are the most common defect in revised manuscripts and are most often detected by reviewers who have already read the paper. The response letter and the manuscript should also agree: if the letter states that a sensitivity analysis was added, the methods section must state this as well, in the same terms.
Finally, the reporting checklist should be reapplied to the revised version. Revisions add text under time pressure, which is precisely when an item addressed in the original version is most likely to be displaced. Response-to-reviewers support covers the letter itself.
Stage 6: proofs and post-publication
At the proof stage, the typeset article is compared against the accepted manuscript rather than improved: dropped or duplicated lines, incorrectly set equations and special characters, figures transposed or wrongly oriented, captions attached to the wrong item, shifted reference numbering, incorrectly linked supplementary files, and author names, affiliations and identifiers. The author list should receive a separate reading, because errors in it persist in the record.
After publication, three actions are advisable. Authors should confirm that the article is deposited where the funder requires and that the data and code are located where the availability statement indicates; a statement referring to a repository that does not contain the data is likely to necessitate a correction. The publication should be registered in the institutional system with the correct licence. Any error identified should be reported to the journal, since a correction published on the authors’ initiative is perceived very differently from one issued after others have identified the error.
Key points
Key points
Checklists are effective when applied to a specific manuscript by a reviewer, and have little effect as documents alone. In a randomised trial, an added review against a reporting guideline increased the proportion of manuscripts that improved from 20% to 43%, whereas across 1,496 diagnostic accuracy articles the mean number of STARD items reported was only 9.1 to 14.3 of 25, improving by 1.41 items after the guideline appeared, and journals endorsing it averaged 15.4 compared with 14.1. The guideline should be used at the protocol stage, because items asking for the rationale of a decision can be answered honestly only before the results exist, and authorship should be settled against all four ICMJE criteria at the same stage. Before submission, manuscripts should be checked against the criteria editors weigh: topic relevance at 95.02%, scope at 92.85% and novelty at 90.47%. Problems tend to occur in groups, since desk-rejected manuscripts averaged three or more recorded reasons each, and the uploaded checklist should map each item to a line rather than consist of a column of ticks.
Application to your study
Application to your study
- The reporting guideline should be named in the protocol. This takes approximately five minutes and organizes the protocol around the items that readers will later require.
- The “why” items should be answered before results are available. These include sample size assumptions, the primary outcome, the analysis model and subgroups; they cannot be answered honestly at a later stage.
- Authorship should be agreed against all four ICMJE criteria at the outset. The criteria that each contributor is expected to meet should be recorded and revisited once the analysis is complete.
- Each unmet item should be classified as a reporting gap or a conduct gap. A reporting gap can be resolved with approximately an hour of writing; a conduct gap is a limitation to be stated explicitly.
- The complete pre-submission list should be worked through, not only the first defect identified. Desk-rejected manuscripts averaged three or more distinct reasons each.
- The checklist should be uploaded with each item mapped to page and line. Unmet items should be marked “not reported” with a reason rather than ticked.
- The checklist should be reapplied after revision. Text added under time pressure is where an item addressed in the original version is most likely to be lost.
- The data availability statement should be verified after publication. A statement that refers to a repository that does not hold the data is likely to necessitate a correction.
Frequently asked questions
Systematic application of a guideline to a specific manuscript does; the existence of the guideline has a much smaller effect. Cobo and colleagues randomised 92 manuscripts in a masked trial in the BMJ: an added review against a reporting guideline raised the proportion improving from baseline from 20% to 43%, a relative risk of 2.21, with approximately 4.2 manuscripts reviewed to improve one. By contrast, Korevaar and colleagues pooled 16 investigations covering 1,496 diagnostic accuracy articles and found that the mean number of STARD items reported was 9.1 to 14.3 out of 25, improving by only 1.41 items after the guideline was published. The effective intervention is the use of the instrument, not the instrument itself.
At the protocol stage, contrary to common practice. Checklists contain two kinds of item: those concerning what was done, which can be answered at any time, and those concerning what was decided and why, such as the sample size assumptions, the primary outcome, the analysis model and the planned subgroups. The second kind can be answered candidly only before the results exist, because thereafter every justification is written in their light. Early use of the guideline also usefully reorganizes the protocol and makes the checklist completed at submission a record rather than a reconstruction.
The guideline should be matched to the design: CONSORT for parallel-group randomised trials, with SPIRIT for the protocol; PRISMA 2020 for systematic reviews, with the extension appropriate to the review type; STARD for diagnostic accuracy studies; STROBE for observational studies, in the cohort, case-control or cross-sectional version; CARE for case reports; COREQ or SRQR for qualitative research; SQUIRE for quality improvement; CHEERS for economic evaluations; TIDieR alongside the main guideline where an intervention must be replicable; and the AGREE reporting checklist for clinical practice guidelines. Where an extension exists for the specific design, it should be used, because the main checklist omits the items that design most requires.
To a limited extent, on the published evidence. Walther and colleagues examined 130 coronary CT angiography studies across 44 journals and found mean STARD scores of 15.4 in journals that had adopted the checklist, compared with 14.1 in those that had not, a statistically significant but small difference, with scores rising by approximately 0.30 points per year overall. Endorsement encourages better reporting but does not enforce it. Authors therefore cannot rely on a journal’s policy to identify what their own checklist review would have identified, and a journal that requests a completed checklist will generally also accept one that accurately marks items as not reported.
Properties of the study and its fit with the journal, not the prose. In Saragih and colleagues’ survey of journal editors, desk evaluation depended on topic relevance (95.02%), conformity with the journal’s scope (92.85%), novelty (90.47%), significance (88.09%) and originality (80.93%). The pre-submission checks that matter are therefore whether the authors can state in one sentence what is new, whether the journal has recently published on the topic using the same design, whether the article type is one the journal lists, and whether the abstract reports the design, population, primary outcome and an effect size with its uncertainty.
Not reliably, because problems tend to occur in groups. In Meyer and colleagues’ audit of 369 manuscripts rejected before external review at Academic Medicine, manuscripts averaged three or more distinct recorded reasons each, whereas a rejection letter usually names one or two. Before resubmission to any journal, the entire pre-submission list should be applied, not only the item identified by the editor, and the findings should be divided into problems that can still be remedied and those determined when the study was designed. The second group constitutes a limitation to be stated, and may be a reason to select a different journal.
Each item should be mapped to a location (section, page and line, together with the supplementary file where relevant) rather than marked in a column of ticks. A tick asserts compliance and requires a reviewer to search the manuscript to verify it; a location map allows the entire list to be checked within a few minutes and tends to improve the tone of the methodological comments received. Where an item is not addressed, it should be marked “not reported” with a brief reason. An acknowledged gap is better received than a tick that does not withstand scrutiny.
Three checks are required. First, that the article is deposited wherever the funder or institution requires, with the correct licence recorded. Second, that the data availability statement is accurate: that the repository it names contains the data and code, in a readable form, under the stated access conditions, since a statement referring to an empty repository is likely to necessitate a correction. Third, that any error identified is reported to the journal promptly: a correction initiated by the authors is perceived very differently from one issued after a reader has identified the error, and the published record will be consulted for many years.
References
- International Committee of Medical Journal Editors. Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. International Committee of Medical Journal Editors. 2026. read 9 October 2026. icmje.org
- Jefferson T, Rudin M, Brodney Folse S, Davidoff F. Editorial peer review for improving the quality of reports of biomedical studies. Cochrane Database of Systematic Reviews. 2007:MR000016. doi:10.1002/14651858.MR000016.pub3 read 9 October 2026. doi.org/10.1002/14651858.MR000016.pub3
- Arsyad S, Zaim M, Othman J. Dealing with journal review results: How successful and productive authors avoid and respond to manuscript rejections. EduLite: Journal of English Education, Literature, and Culture. 2026;11(1):34-48. doi:10.30659/e.11.1.34-48 read 9 October 2026. doi.org/10.30659/e.11.1.34-48
- Cyberpsychology: Journal of Psychosocial Research on Cyberspace (editors). Decisions and Reviews Statistics for 2024. Cyberpsychology: Journal of Psychosocial Research on Cyberspace. 2024. read 9 October 2026. cyberpsychology.eu
- Saragih E, Saddhono K, Yannuar N, Sumbayak DM. Scholarly Manuscript Assessment: Scientific Journal Editor Desk Evaluation. Malaysian Journal of Library & Information Science. 2024;29(2):1-18. doi:10.22452/mjlis.vol29no2.1 read 9 October 2026. doi.org/10.22452/mjlis.vol29no2.1
- Yanik B, Evcik D, Geler Kulcu D, Koldas Dogan S, Bardak AN, Zateri C, Sonel Tur B. Why do manuscripts submitted to the Turkish Journal of Physical Medicine and Rehabilitation get rejected? Turkish Journal of Physical Medicine and Rehabilitation. 2023;69(4):535-540. doi:10.5606/tftrd.2023.13204 read 9 October 2026. doi.org/10.5606/tftrd.2023.13204
- Reed H, Dehn RW, Bushardt RL. Reasons for unsuccessful research submissions to JAAPA. Journal of the American Academy of Physician Assistants. 2022;35(5):54-56. doi:10.1097/01.JAA.0000824948.31791.0b read 9 October 2026. doi.org/10.1097/01.JAA.0000824948.31791.0b
- Menon V, Varadharajan N, Praharaj SK, Ameen S. Why Do Manuscripts Get Rejected? A Content Analysis of Rejection Reports from the Indian Journal of Psychological Medicine. Indian Journal of Psychological Medicine. 2022;44(1):59-65. doi:10.1177/0253717620965845 read 9 October 2026. doi.org/10.1177/0253717620965845
- Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. doi:10.1136/bmj.n160 read 9 October 2026. doi.org/10.1136/bmj.n160
- Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021:n71. doi:10.1136/bmj.n71 read 9 October 2026. doi.org/10.1136/bmj.n71
- Lee J, Yang K, Oh DG. Factors influencing the choice of a publication venue in library and information science. Learned Publishing. 2020;33(3):323-332. doi:10.1002/leap.1300 read 9 October 2026. doi.org/10.1002/leap.1300
- Editage / UKSG (report summary). Can language editing improve manuscript acceptance rates? UKSG (report summary). 2019. read 9 October 2026. uksg.org
- Science Editing (survey report). Authors' perspectives on academic publishing: initial observations from a large-scale global survey. Science Editing. 2018. read 9 October 2026. doaj.org
- Meyer HS, Durning SJ, Sklar DP, Maggio LA. Making the first cut: an analysis of academic medicine editors' reasons for not sending manuscripts out for external peer review. Academic Medicine. 2018;93(3):464-470. doi:10.1097/ACM.0000000000001860 read 9 October 2026. doi.org/10.1097/ACM.0000000000001860
- Massimo L, Codato A. On the immediate rejection of manuscripts without external peer review. SciELO in Perspective (Revista de Sociologia e Politica). 2016. read 9 October 2026. blog.scielo.org
- Shen C, Bjork B-C. Predatory open access: a longitudinal study of article volumes and market characteristics. BMC Medicine. 2015. doi:10.1186/s12916-015-0469-2 read 9 October 2026. doi.org/10.1186/s12916-015-0469-2
- Walther S, Schueler S, Tackmann R, Schuetz GM, Schlattmann P, Dewey M. Compliance with STARD Checklist among Studies of Coronary CT Angiography: Systematic Review. Radiology. 2014;271(1). doi:10.1148/radiol.13121720 read 9 October 2026. doi.org/10.1148/radiol.13121720
- Korevaar DA, van Enst WA, Spijker R, Bossuyt PMM, Hooft L. Reporting quality of diagnostic accuracy studies: a systematic review and meta-analysis of investigations on adherence to STARD. Evidence-Based Medicine. 2014;19(2):47-54. doi:10.1136/eb-2013-101637 read 9 October 2026. doi.org/10.1136/eb-2013-101637
- Journal of Guilan University of Medical Sciences (study report). Accuracy of References Used in Research Articles Published By the Journal of Guilan University of Medical Sciences. Journal of Guilan University of Medical Sciences. 2013;22(86):78. read 9 October 2026. magiran.com
- Lee CJ, Sugimoto CR, Zhang G, Cronin B. Bias in peer review. Journal of the American Society for Information Science and Technology. 2013;64(1):2-17. doi:10.1002/asi.22784 read 9 October 2026. doi.org/10.1002/asi.22784
- Dalton M. Traditional Factors of Fit, Perceived Quality, and Speed of Publication Still Outweigh Open Access in Authors' Journal Selection Criteria. Evidence Based Library and Information Practice. 2012;7(4):102-104. doi:10.18438/B8HC87 read 9 October 2026. doi.org/10.18438/B8HC87
- Cobo E, Cortes J, Ribera JM, Cardellach F, Selva-O'Callaghan A, Kostov B, et al. Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial. BMJ. 2011;343:d6783. doi:10.1136/bmj.d6783 read 9 October 2026. doi.org/10.1136/bmj.d6783
- Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials. 2010;11(1):32. doi:10.1186/1745-6215-11-32 read 9 October 2026. doi.org/10.1186/1745-6215-11-32
- Singh S, Chaudhary R. Accuracy of references cited in articles published in Indian Journal of Dermatology, Venereology and Leprology: A pilot study. Indian Journal of Dermatology, Venereology and Leprology. 2009;75(5):488-491. doi:10.4103/0378-6323.55392 read 9 October 2026. doi.org/10.4103/0378-6323.55392
- Rowe N, Ilic D. What impact do posters have on academic knowledge transfer? A pilot survey on author attitudes and experiences. BMC Medical Education. 2009;9:71. doi:10.1186/1472-6920-9-71 read 9 October 2026. doi.org/10.1186/1472-6920-9-71
- Cobo E, Selva-O'Callaghan A, Ribera JM, Cardellach F, Dominguez R, Vilardell M. Statistical Reviewers Improve Reporting in Biomedical Articles: A Randomized Trial. PLoS ONE. 2007;2(3):e332. doi:10.1371/journal.pone.0000332 read 9 October 2026. doi.org/10.1371/journal.pone.0000332
- Jefferson T, Shashok K. Journals: how to decide what's worth publishing. Nature. 2003;421:209-210. read 9 October 2026. drtomjefferson.com
- Meadows J. Editorial peer review: its strengths and weaknesses. Journal of Documentation. 2002;58(1):104-106. read 9 October 2026. garfield.library.upenn.edu
- DeMaria AN. Peer review: better than the alternatives. Journal of the American College of Cardiology. 2002;40(5):1017-1018. read 9 October 2026. garfield.library.upenn.edu
- Rowland F. The peer-review process. Learned Publishing. 2002;15(4):247-258. read 9 October 2026. garfield.library.upenn.edu
- van Rooyen S, Godlee F, Evans S, Black N, Smith R. Effect of open peer review on quality of reviews and on reviewers' recommendations: a randomised trial. BMJ. 1999;318(7175):23-27. doi:10.1136/bmj.318.7175.23 read 9 October 2026. doi.org/10.1136/bmj.318.7175.23
- Ngan Kee WD, Roach VJ, Lau TK. The accuracy of references in the Hong Kong Medical Journal. Hong Kong Medical Journal. 1997;3(4):377-380. read 9 October 2026. hkmj.org
Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 9). Checklists for Each Stage of the Publication Journey: Timing, Evidence and Use. Pubrica. https://pubrica.com/academy/journal-selection/critical-checklists-to-support-you-on-your-scientific-publication-journey-at-each-point/
Pubrica Academy. “Checklists for Each Stage of the Publication Journey: Timing, Evidence and Use.” Pubrica, 9 Oct. 2026, pubrica.com/academy/journal-selection/critical-checklists-to-support-you-on-your-scientific-publication-journey-at-each-point/.
Pubrica Academy (2026) Checklists for Each Stage of the Publication Journey: Timing, Evidence and Use. Pubrica. Available at: https://pubrica.com/academy/journal-selection/critical-checklists-to-support-you-on-your-scientific-publication-journey-at-each-point/ (Accessed: 15 October 2026).
Pubrica Academy. “Checklists for Each Stage of the Publication Journey: Timing, Evidence and Use.” Pubrica. October 9, 2026. https://pubrica.com/academy/journal-selection/critical-checklists-to-support-you-on-your-scientific-publication-journey-at-each-point/
Pubrica Academy, ‘Checklists for Each Stage of the Publication Journey: Timing, Evidence and Use’ (Pubrica, 9 October 2026) <https://pubrica.com/academy/journal-selection/critical-checklists-to-support-you-on-your-scientific-publication-journey-at-each-point/> accessed 15 October 2026.
Pubrica Academy. Checklists for Each Stage of the Publication Journey: Timing, Evidence and Use. [Internet]. Pubrica; 2026 Oct 9 [cited 2026 Oct 15]. Available from: https://pubrica.com/academy/journal-selection/critical-checklists-to-support-you-on-your-scientific-publication-journey-at-each-point/
Pubrica Academy, “Checklists for Each Stage of the Publication Journey: Timing, Evidence and Use,” Pubrica, Oct. 9, 2026. [Online]. Available: https://pubrica.com/academy/journal-selection/critical-checklists-to-support-you-on-your-scientific-publication-journey-at-each-point/
@misc{critical_checklists_to_support_you_on__2026,
author = {{Pubrica Academy}},
title = {Checklists for Each Stage of the Publication Journey: Timing, Evidence and Use},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/academy/journal-selection/critical-checklists-to-support-you-on-your-scientific-publication-journey-at-each-point/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Stage-by-stage checklist you can copy
Six blocks, one for each stage. Each block should be completed and dated at its stage; the dates show whether a check was performed when it could still influence the work, or afterwards, when it could only be recorded.
PUBLICATION JOURNEY CHECKLIST
Project: ______________________ Reporting guideline: ______________________
STAGE 1 - PROTOCOL date: ____/____/____
[ ] Question in one sentence: ____________________________
[ ] Design, and why it answers that question: ____________
[ ] SINGLE primary outcome, measure and time point: ______
[ ] Sample size, with the assumptions written out: _______
[ ] Analysis plan: population analysed, missing data, model
[ ] Subgroups and sensitivity analyses pre-specified: ____
[ ] Registered prospectively: registry ______ number ______
[ ] Ethics approval: committee ______ reference ______
[ ] Consent arrangements, including identifiable material
[ ] Data management and sharing plan
[ ] Author list, with the ICMJE criteria each is expected to meet
[ ] Reporting guideline NAMED and used to structure the protocol
STAGE 2 - DRAFTING date: ____/____/____
[ ] Guideline worked item by item; location recorded per item
Items addressed: ______ of ______
Unmet items, classified:
______________________ [ ] reporting gap [ ] conduct gap
______________________ [ ] reporting gap [ ] conduct gap
[ ] Results report the primary outcome first
[ ] Estimates with dispersion and intervals, exact p values
[ ] Limitations name specific limits, not generic caution
[ ] Abstract drafted LAST, after results were final
STAGE 3 - PRE-SUBMISSION date: ____/____/____
[ ] What is new, in one sentence: ________________________
[ ] Why this journal's readers need it: __________________
[ ] Two of the journal's own recent papers cited as context
[ ] Article type listed by the journal: __________________
word limit ______ current count ______
[ ] Abstract gives design, population, primary outcome, effect
size with uncertainty; conclusion bounded by the data
[ ] WHOLE list worked, not stopped at the first problem found
STAGE 4 - SUBMISSION date: ____/____/____
[ ] Ethics reference, consent, funding, conflicts, data statement
[ ] Registration number and date
[ ] Author contributions itemised
[ ] Each author confirmed against ALL FOUR ICMJE criteria
[ ] Prior presentation / preprint / thesis declared
[ ] Completed checklist uploaded, ITEM-MAPPED to page and line
[ ] Final version read by the person approving it
STAGE 5 - REVISION date: ____/____/____
Comments sorted:
factually answerable ...... ____
fixable with work now ..... ____
settled at design stage ... ____
[ ] Every changed number reconciled: abstract, text, tables,
figures, discussion
[ ] Response letter and manuscript agree, in the same terms
[ ] Reporting checklist RE-RUN on the revised version
STAGE 6 - PROOF AND AFTER date: ____/____/____
[ ] Proof compared against the ACCEPTED file
[ ] Equations, symbols, figures, captions, reference numbering
[ ] Author names, affiliations, identifiers read separately
[ ] Deposited where the funder requires; licence recorded
[ ] Data and code actually present where the statement says
[ ] Any error found reported to the journal promptly Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.
How Pubrica can help
Pubrica provides the review that the randomised evidence supports: the protocol or manuscript is assessed item by item against the guideline appropriate to its design and returned with each item mapped to page and line, and every unmet item is classified as either a reporting gap that can still be closed or a conduct gap that cannot. At the protocol stage, the same items are used as design prompts, where they are most useful and least costly.